Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38598794

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2024 Apr 11
First author
Wu YL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Lung Cancer Res. 2024 Dec 31;13(12):3815-3818. doi: 10.21037/tlcr-24-844.
    note
    Source null
    related pmid
    39830747
    relationship
    Comment in
  2. citation
    Transl Lung Cancer Res. 2025 Feb 28;14(2):310-313. doi: 10.21037/tlcr-24-961.
    note
    Source null
    related pmid
    40114944
    relationship
    Comment in

Authors and identifiers

  1. name
    Wu YL
    type
    Author
  2. name
    Dziadziuszko R
    type
    Author
  3. name
    Ahn JS
    type
    Author
  4. name
    Barlesi F
    type
    Author
  5. name
    Nishio M
    type
    Author
  6. name
    Lee DH
    type
    Author
  7. name
    Lee JS
    type
    Author
  8. name
    Zhong W
    type
    Author
  9. name
    Horinouchi H
    type
    Author
  10. name
    Mao W
    type
    Author
  11. name
    Hochmair M
    type
    Author
  12. name
    de Marinis F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wu YL
    type
    Author
  2. name
    Dziadziuszko R
    type
    Author
  3. name
    Ahn JS
    type
    Author
  4. name
    Barlesi F
    type
    Author
  5. name
    Nishio M
    type
    Author
  6. name
    Lee DH
    type
    Author
  7. name
    Lee JS
    type
    Author
  8. name
    Zhong W
    type
    Author
  9. name
    Horinouchi H
    type
    Author
  10. name
    Mao W
    type
    Author
  11. name
    Hochmair M
    type
    Author
  12. name
    de Marinis F
    type
    Author
bibliography ids
  1. nci-bib-6c5b1c2fe1424362066e0e13
book metadata
content sha256
ebe452f635cfa6347bb420654bb3f7822c3d6a96ecb36eb7a680b6ca4ad9a658
document type
citation
dois
  1. 10.1056/NEJMoa2310532
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:38598794
immutable id
pubmed:38598794@ebe452f635cfa6347bb420654bb3f7822c3d6a96ecb36eb7a680b6ca4ad9a658
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
14
name
The New England journal of medicine
nlm unique id
0255562
pages
1265-1276
volume
390
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Lung Cancer Res. 2024 Dec 31;13(12):3815-3818. doi: 10.21037/tlcr-24-844.
    note
    Source null
    related pmid
    39830747
    relationship
    Comment in
  2. citation
    Transl Lung Cancer Res. 2025 Feb 28;14(2):310-313. doi: 10.21037/tlcr-24-961.
    note
    Source null
    related pmid
    40114944
    relationship
    Comment in
outcomes validated
false
pmid
38598794
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
6d4ca35e12c2804315cde0c36d64ffd2f8c74c9e177f0ebef04263416e908c58
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Apr 11
precision
day
year
2024
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38598794/
title
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Preserved source evidence · Not medical advice